Enoxaparin 300mg/3mL Injection Pen

Enoxaparin 300mg/3mL Injection Pen is a low-molecular-weight heparin anticoagulant used to prevent or treat harmful blood clots. Its uses include deep vein thrombosis, pulmonary embolism, clot prevention around surgery or reduced mobility, and selected acute coronary syndromes.
Enoxaparin is usually injected under the skin, not into a muscle. Rotate injection sites and do not rub the area afterwards. Home injection requires practical training. Some acute heart-attack regimens include an intravenous dose given by the clinical team; this is not an instruction for home IV use.
Enoxaparin enhances antithrombin activity, inhibiting factor Xa more strongly than thrombin. This reduces new clot formation and extension of existing clots.
Possible effects include injection-site bruising, bleeding, anemia, nausea, fever, swelling, and raised liver enzymes. Serious warning signs include unusual bleeding, black stools, blood in urine, severe headache, weakness, back pain after spinal procedures, allergic reaction, low platelets, or skin necrosis.
Tell the clinician about bleeding disorders, ulcers, recent surgery, stroke, kidney disease, spinal/epidural anesthesia, heparin allergy, HIT history, pregnancy, breastfeeding, low body weight, older age, and use of NSAIDs, aspirin, antiplatelets, or anticoagulants.
Provides predictable anticoagulant effect for clot prevention and treatment, often without the same frequent monitoring required by unfractionated heparin in routine use.
It is used to prevent or treat harmful blood clots. The 300mg/3mL figure describes the total medicine in the device, not an automatic single injection dose.
No. It helps stop clots from growing and reduces new clot formation while the body gradually breaks clots down.
Enoxaparin clearance depends partly on kidney function, so dose or monitoring may change in kidney impairment.
Black stools, blood in urine, vomiting blood, severe headache, heavy bruising, unusual weakness, or uncontrolled bleeding needs urgent care.
NSAIDs such as ibuprofen or diclofenac can increase bleeding risk and should be reviewed before use.
Anticoagulation around spinal procedures can rarely cause spinal bleeding, which may lead to nerve damage.
Low-molecular-weight heparin: an anticoagulant class including enoxaparin. DVT: a clot in a deep vein. Pulmonary embolism: obstruction of a lung blood vessel by a clot. Factor Xa: a clotting enzyme inhibited by enoxaparin through antithrombin. HIT: heparin-induced thrombocytopenia, an immune reaction associated with clotting and low platelets.; AR: Enoxaparin 300mg/3mL Pen حقن; FR: Enoxaparin 300mg/3mL Pen injection; PT: Enoxaparin 300mg/3mL Pen injeção; ES: Enoxaparin 300mg/3mL Pen inyección; RU: Enoxaparin 300mg/3mL Pen инъекция; ID: Enoxaparin 300mg/3mL Pen injeksi; VI: Enoxaparin 300mg/3mL Pen thuốc tiêm; MS: Enoxaparin 300mg/3mL Pen suntikan; TL: Enoxaparin 300mg/3mL Pen iniksyon; ZH-SG: Enoxaparin 300mg/3mL Pen 注射剂
International B2B Enquiry
Send a structured B2B enquiry for Enoxaparin 300mg/3mL Injection Pen under Blood Care. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Enoxaparin 300mg/3mL Injection Pen